While Mesoblast Limited ACN 109 431 870 (Mesoblast) has endeavoured to ensure that all information provided on the Mesoblast website is accurate and up to date, Mesoblast is not liable for any error, omission, misrepresentation or misstatement relating to this information.

 

Last Share Price

August 28 - Mesoblast Reports Significant Achievements and Strong Financial Position

August 21 - Mesoblast's Allogeneic "Off -The-Shelf" stem cells are safe and effective for Cervical Spine Fusion

August 12 - Mesoblast's Stem Cells Regrow Knee Cartilage in Severe Post-Menopausal Osteoarthritis

August 07 - Mesoblast - National Electronic Media coverage

May 2008 - Issue Nine

September 2007 - Issue Eight

March 2007 - Issue Seven

August 2006 - Issue Six